UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.55 -1.08 (-1.31%) GOLD FUTURES
2,297.30 -60.40 (-2.56%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,092.37 -2,323.54 (-4.61%)
Schrödinger, Inc. (SDGR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.44 |
| Open | 24.06 |
| Bid | 24.33 x 300 |
| Ask | 24.45 x 300 |
| Day's range | 23.97 - 24.56 |
| 52-week range | 20.76 - 59.24 |
| Volume | |
| Avg. volume | 868,087 |
| Market cap | 1.772B |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | 45.15 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, April 18, 2024--Schrödinger today reported that on April 15, 2024, the company granted (i) non-statutory stock options and (ii) restricted stock units (RSUs).
- Business Wire
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
NEW YORK, April 10, 2024--Schrödinger will report its first quarter 2024 financial results on Wednesday, May 1, 2024, after the financial markets close.
- Business Wire
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
NEW ORLEANS, March 20, 2024--Schrödinger today presented the discovery of SGR-1505, its MALT1 inhibitor, during the American Chemical Society (ACS) Spring 2024 Meeting.
© 2024 Yahoo. All rights reserved.